Event Recordings

Joseph Wu, M.D., Ph.D.
Director, Stanford Cardiovascular Institute
Simon H. Stertzer, M.D., Professor of Medicine and Radiology

Lloyd Minor, M.D.
Dean, Stanford School of Medicine 

Marc Tessier-Lavigne, Ph.D.
President, Stanford University

Introduction of Katalin Karikó, PhD by:
Randy Schekman, Ph.D.
Professor of Molecular and Cell Biology, University of California, Berkeley; 2013 Nobel Laureate

Katalin Karikó, Ph.D.
Senior Vice President, BioNTech

Randy Schekman, Ph.D.
Professor of Molecular and Cell Biology, University of California, Berkeley; 2013 Nobel Laureate

Moderator: Myrtle Davis, D.V.M., Ph.D.
Scientific Vice President, Discovery Toxicology, Bristol Myers Squibb

Co-Moderator: Mark Mercola, Ph.D.
Professor of Medicine, Stanford University School of Medicine

Speakers:

Claude Bertrand, Ph.D.
Executive Vice President R&D, Chief Scientific Officer, Servier
Servier: A New Paradigm for R&D through a significant Transformation Journey

Dean Li, M.D., Ph.D.
Executive VP and President of Merck Research Laboratories 
The Balance of Computing Power and Human Intelligence

Ray Deshaies, Ph.D.
Senior Vice President, Global Research, Amgen 
Multispecific Molecular Medicines

Carlos O. Garner, Ph.D. 
Vice President, Global Regulatory Affairs, Eli Lilly and Company
How COVID Will Reshape Clinical Research

Panel Discussion

Moderator: Myrtle Davis, D.V.M., Ph.D.
Scientific Vice President, Discovery Toxicology, Bristol Myers Squibb

Co-Moderator: Mark Mercola, Ph.D.
Professor of Medicine, Stanford University School of Medicine

Speakers:

Claude Bertrand, Ph.D.
Executive Vice President R&D, Chief Scientific Officer, Servier

Dean Li, M.D., Ph.D.
Executive VP and President of Merck Research Laboratories

Ray Deshaies, Ph.D.
Senior Vice President, Global Research, Amgen

Carlos O. Garner, Ph.D.
Vice President, Global Regulatory Affairs, Eli Lilly and Company

Moderator: Karin Immergluck, Ph.D.
Executive Director, Stanford Office of Technology Licensing (OTL)

Co-Moderator: Kuldev Singh, M.D.
Professor of Ophthalmology, Stanford University School of Medicine

Speakers:
Hogene Choi, J.D.
Partner, Morrison & Foerster
Strategies for Protecting Software Innovation in Drug Discovery

Madhuri Roy, J.D., Ph.D.
Partner, Patent Counseling & Prosecution, Cooley
Getting your IP House In Order

Vern Norviel, J.D.
Partner, Patents and Innovations, Wilson Sonsini
Drug Label Patent Extension

Panel Discussion

Moderator: Karin Immergluck, Ph.D.
Executive Director, Stanford Office of Technology Licensing (OTL)

Co-Moderator: Kuldev Singh, M.D.
Professor of Ophthalmology, Stanford University School of Medicine

Speakers:

Hogene Choi, J.D.
Partner, Morrison & Foerster

Madhuri Roy, J.D., Ph.D.
Partner, Patent Counseling & Prosecution, Cooley

Vern Norviel, J.D.
Partner, Patents and Innovations, Wilson Sonsini

Moderator: Steven Artandi, M.D., Ph.D.
Laurie Kraus Lacob Director (SCI); Jerome and Daisy Low Gilbert Professor (Med and Biochem), Stanford

Co-Moderator: Mark Mercola, Ph.D.
Professor of Medicine, Stanford University School of Medicine

Speakers:

Michelle McMurry-Heath, M.D.
President & Chief Executive Officer, Biotechnology Innovation Organization
The Distribution of Scientific Progress: The Social Justice Issue of our Age

Gary Gibbons, M.D.
Director, NHLBI
Accelerating the Cycle of Innovation for Drug Discovery to Prevent and Preempt Chronic Disease

Jacqueline Corrigan-Curay, J.D., M.D.
Principal Deputy Center Director, FDA, CDER
Evidence Generation – Enhancing Access and Equity

Maria Millan, M.D.
President and Chief Executive Officer, CIRM

Panel Discussion

Moderator: Steven Artandi, M.D., Ph.D.
Laurie Kraus Lacob Director (SCI); Jerome and Daisy Low Gilbert Professor (Med and Biochem), Stanford

Co-Moderator: Mark Mercola, Ph.D.
Professor of Medicine, Stanford University School of Medicine

Speakers:

Michelle McMurry-Heath, M.D.
President & Chief Executive Officer, Biotechnology Innovation Organization

Jacqueline Corrigan-Curay, J.D., M.D.
Principal Deputy Center Director, FDA, CDER

Maria Millan, M.D.
President and Chief Executive Officer, CIRM

Moderator: Sandra Horning, M.D.
Board of Directors: Gilead, Moderna, & Olema Pharma. Co-founder & Advisor, EQRx

Co-Moderator: Sanjay Malhotra, Ph.D.
Professor, Cell, Developmental & Cancer Biology; Director, Center for Experimental Therapeutics, OHSU

Speakers:
Alfred Sandrock, M.D., Ph.D.
CEO, Voyager Therapeutics
The Discovery and Development of Aducanumab for Alzheimer’s Disease

Lisa Coussens, Ph.D.
President, American Association of Cancer Research; Associate Director for Basic Research, Knight Cancer Institute, Oregon Health & Science University
Neutralizing Protumor Inflammation: Lessons Learned from Preclinical Mouse Models

Randy Schekman, Ph.D.
Professor of Molecular and Cell Biology, University of California, Berkeley; 2013 Nobel Laureate
Engineering a Membrane-Mediated Delivery of Genome Editing Functions
 
Panel Discussion

Moderator: Sandra Horning, M.D.
Board of Directors: Gilead, Moderna, & Olema Pharma. Co-founder & Advisor, EQRx

Co-Moderator: Sanjay Malhotra, Ph.D.
Professor, Cell, Developmental & Cancer Biology; Director, Center for Experimental Therapeutics, OHSU

Speakers:

Alfred Sandrock, M.D., Ph.D.
CEO, Voyager Therapeutics

Lisa Coussens, Ph.D.
President, American Association of Cancer Research; Associate Director for Basic Research, Knight Cancer Institute, Oregon Health & Science University

Randy Schekman, Ph.D.
Professor of Molecular and Cell Biology, University of California, Berkeley; 2013 Nobel Laureate

Joseph Wu, MD, PhD
Director, Stanford CVI
Simon H. Stertzer, MD, Professor, Department of Medicine and Radiology
Stanford University School of Medicine